Skip to main content

Ensysce Biosciences Inc (ENSC) Stock

Ensysce Biosciences Inc Stock Details, Movements and Public Alerts

Stock Details

Ensysce Biosciences Inc (ENSC), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.43. Over the past 52 weeks, it has ranged between $0.31 and $4.85. This places the current price at 8.9% of its 52-week high and 36.9% above its 52-week low. Recent trading volume was recorded at 320,054. The 14-day Relative Strength Index (RSI) stands at 44.47, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.75 by 42.67%. Similarly, it is below its 200-day moving average of $1.76 by 75.57%. The MACD histogram is 0.04, indicating bullish momentum (MACD Line: -0.07, Signal Line: -0.11).

52-Week Range

$4.85 - $0.31

-91.13% from high · +36.94% from low

Avg Daily Volume

17,296,710

20-day average

100-day avg: 3,610,561

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

0.76

Price to Book

1.25

EV/EBITDA

-0.50

EPS (TTM)

-$6.35

Price to Sales

0.33

Beta

1.16

Similar volatility to market

Q:How is ENSC valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is ENSC's risk profile compared to the market?
With a beta of 1.16, Ensysce Biosciences Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.25 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-244.50%

Operating Margin

-759.00%

EBITDA

$-24,221,944

Return on Equity

-294.40%

Return on Assets

-109.80%

Revenue Growth (YoY)

-85.60%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is ENSC's business model?
Ensysce Biosciences Inc achieves a profit margin of -244.50%, meaning it retains $-244.50 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -759.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -294.40% and ROA at -109.80%, the company achieves moderate returns on invested capital.
Q:What are ENSC's recent growth trends?
Ensysce Biosciences Inc's revenue declined by 85.60% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$1.5M

Revenue (TTM)

$4.49M

Revenue/Share (TTM)

$2.32

Shares Outstanding

3.63M

Book Value/Share

$0.38

Asset Type

Common Stock

Q:What is ENSC's market capitalization and position?
Ensysce Biosciences Inc has a market capitalization of $1.5M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 3.63M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does ENSC's price compare to its book value?
Ensysce Biosciences Inc's book value per share is $0.38, while the current stock price is $0.43, resulting in a price-to-book (P/B) ratio of 1.14. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$16.45

3725.58% upside potential

Analyst Recommendations

No analyst ratings available

Q:How reliable are analyst predictions for ENSC?
0 analysts cover ENSC with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $16.45 implies 3725.6% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on ENSC?
Current analyst recommendations:00000The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 15, 2026, 02:48 AM

Technical Indicators

RSI (14-day)

44.47

Neutral

50-Day Moving Average

$0.75

-42.67% below MA-50

200-Day Moving Average

$1.76

-75.57% below MA-200

MACD Line

-0.07

MACD Signal

-0.11

MACD Histogram

0.04

Bullish

Q:What does ENSC's RSI value tell investors?
The RSI (Relative Strength Index) for ENSC is currently 44.47, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret ENSC's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.07 above the signal line at -0.11, with histogram at 0.04. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.75) is below the 200-day MA ($1.76), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Mar 5, 2026, 12:47 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for ENSC and get notified when the price changes.

Stay Ahead of the Market with Ensysce Biosciences Inc Alerts

Set up price alerts for Ensysce Biosciences Inc and get notified instantly when the price hits your target. Never miss an important price movement again.